Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/29/2023 | PROKIDNEY CORP. | | Grant | Director stock option (right to buy) | 48.1k | $10.56 | $508.2k | | 06/29/2023 |
06/28/2023 | Royalty Pharma plc | RPRX | Purchase | Class A ordinary shares | 130k | $29.51 | $3.8M | By Legorreta 2023 SR Trust | 06/28/2023 |
05/24/2023 | Royalty Pharma plc | RPRX | Purchase | Class A ordinary shares | 150k | $32.25 | $4.8M | By Legorreta 2023 SR Trust | 05/24/2023 |
05/17/2023 | Royalty Pharma plc | RPRX | Purchase | Class A ordinary shares | 69.6k | $32.94 | $2.3M | By Legorreta 2023 SR Trust | 05/16/2023 |
05/16/2023 | Royalty Pharma plc | RPRX | Purchase | Class A ordinary shares | 160.4k | $33.57 | $5.4M | By Legorreta 2023 SR Trust | 05/16/2023 |
05/12/2023 | Royalty Pharma plc | RPRX | Gift | ICAI Interests | 10.3k | $0.00 | $0 | By Spouse | 05/12/2023 |
05/12/2023 | Royalty Pharma plc | RPRX | Gift | ICAI Interests | 10.3k | $0.00 | $0 | | 05/12/2023 |
08/12/2022 | Epizyme, Inc. | EPZM | Other | Common Stock, par value $0.0001 | 31.9M | $0.00 | $0 | See footnotes | 08/12/2022 |
08/12/2022 | Epizyme, Inc. | EPZM | Disposition | Restricted Stock Units | 8.1k | $0.00 | $0 | | 08/12/2022 |
08/12/2022 | Epizyme, Inc. | EPZM | Disposition | Restricted Stock Units | 9k | $0.00 | $0 | | 08/12/2022 |
07/11/2022 | PROKIDNEY CORP. | | Grant | Common Units in ProKidney LP | 94.7M | $0.00 | $0 | See footnote | 07/11/2022 |
07/11/2022 | PROKIDNEY CORP. | | Grant | Earnout Rights | 10.5M | $0.00 | $0 | See footnote | 07/11/2022 |
05/17/2022 | Epizyme, Inc. | EPZM | Grant | Stock Option (Right to Buy) | 41k | $0.56 | $23k | | 05/17/2022 |
05/17/2022 | Epizyme, Inc. | EPZM | Grant | Restricted Stock Units | 9k | $0.00 | $0 | | 05/17/2022 |
04/14/2022 | Royalty Pharma plc | RPRX | Other (disposition) | Class A Ordinary Shares | 462k | $0.00 | $0 | By Legorreta Investments II LLC | 06/16/2020 |
04/14/2022 | Royalty Pharma plc | RPRX | Other (disposition) | Class A Ordinary Shares | 350k | $0.00 | $0 | | 06/16/2020 |
01/31/2022 | Epizyme, Inc. | EPZM | Purchase | Common Stock | 22.7M | $1.50 | $34M | See footnotes | 01/31/2022 |
06/30/2021 | Royalty Pharma plc | RPRX | Other (acquisition) | ICAI Interests | 73.3k | $0.00 | $0 | | 06/16/2020 |
06/11/2021 | Epizyme, Inc. | EPZM | Grant | Restricted Stock Units | 8.1k | $0.00 | $0 | | 06/11/2021 |
06/11/2021 | Epizyme, Inc. | EPZM | Grant | Stock Option (Right to Buy) | 40.6k | $8.53 | $346k | | 06/11/2021 |
05/07/2021 | Royalty Pharma plc | RPRX | Conversion | Class A Ordinary Shares | 1M | $0.00 | $0 | By Legorreta Children 2002 Trust | 05/07/2021 |
05/07/2021 | Royalty Pharma plc | RPRX | Conversion | Class A Ordinary Shares | 1.3M | $0.00 | $0 | By GST-Exempt Legorreta 2012 Family Trust | 05/07/2021 |
05/07/2021 | Royalty Pharma plc | RPRX | Conversion | LP interests in RPI US Partners 2019, LP | 104k | $0.00 | $0 | By Legorreta Children 2002 Trust | 05/07/2021 |
05/07/2021 | Royalty Pharma plc | RPRX | Conversion | LP interests in RPI US Partners 2019, LP | 128.5k | $0.00 | $0 | By GST-Exempt Legorreta 2012 Family Trust | 05/07/2021 |
03/23/2021 | Royalty Pharma plc | RPRX | Other (acquisition) | LP interests in RPI US Partners 2019, LP | 15.9k | $0.00 | $0 | By Legorreta Investments LLC | 06/16/2020 |
03/23/2021 | Royalty Pharma plc | RPRX | Other (acquisition) | LP interests in RPI US Partners 2019, LP | 16k | $0.00 | $0 | By Legorreta Investments II LLC | 06/16/2020 |
10/20/2020 | Royalty Pharma plc | RPRX | Conversion | Class A Ordinary Shares | 428.4k | $0.00 | $0 | By Legorreta Investments LLC | 06/16/2020 |
10/20/2020 | Royalty Pharma plc | RPRX | Conversion | LP interests in RPI US Partners 2019, LP | 42.8k | $0.00 | $0 | By Legorreta Investments LLC | 06/16/2020 |
06/18/2020 | Royalty Pharma plc | RPRX | Conversion | LP interests in RPI International Holdings 2019, LP | 12.3k | $0.00 | $0 | By IRRA | 06/15/2020 |
06/18/2020 | Royalty Pharma plc | RPRX | Conversion | LP interests in RPI International Holdings 2019, LP | 11.8k | $0.00 | $0 | By SEP/ IRA | 06/15/2020 |
06/18/2020 | Royalty Pharma plc | RPRX | Conversion | Class A Ordinary Shares | 118.5k | $0.00 | $0 | By SEP/IRA | 06/15/2020 |
06/18/2020 | Royalty Pharma plc | RPRX | Conversion | Class A Ordinary Shares | 123.3k | $0.00 | $0 | By IRRA | 06/15/2020 |
06/18/2020 | Royalty Pharma plc | RPRX | Purchase | Class A Ordinary Shares | 10k | $28.00 | $280k | By Child | 06/15/2020 |
06/16/2020 | Royalty Pharma plc | RPRX | Conversion | LP interests in RPI US Partners 2019, LP | 49.4k | $0.00 | $0 | By Legorreta Investments LLC | 06/16/2020 |
06/16/2020 | Royalty Pharma plc | RPRX | Conversion | Class A Ordinary Shares | 493.8k | $0.00 | $0 | By Legorreta Investments LLC | 06/16/2020 |
|